X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5) 5
index medicus (5) 5
oncology (5) 5
cancer (4) 4
clinical trials (4) 4
temozolomide (4) 4
adult (3) 3
aged (3) 3
aged, 80 and over (3) 3
brain cancer (3) 3
brain neoplasms - drug therapy (3) 3
chemotherapy (3) 3
female (3) 3
glioblastoma (3) 3
male (3) 3
medical research (3) 3
middle aged (3) 3
studies (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
bevacizumab (2) 2
brain neoplasms - mortality (2) 2
brain neoplasms - radiotherapy (2) 2
brain tumors (2) 2
cancer therapies (2) 2
clinical-trials (2) 2
dacarbazine - analogs & derivatives (2) 2
dacarbazine - therapeutic use (2) 2
disease progression (2) 2
disease-free survival (2) 2
glioblastoma - drug therapy (2) 2
hematology, oncology and palliative medicine (2) 2
medicine, general & internal (2) 2
quality of life (2) 2
radiotherapy (2) 2
tumors (2) 2
1st-line treatment (1) 1
610 medicine & health (1) 1
abridged index medicus (1) 1
adjuvant (1) 1
adolescents (1) 1
adult patients (1) 1
analysis (1) 1
anaplastic oligodendroglioma (1) 1
antineoplastic agents, alkylating - administration & dosage (1) 1
antineoplastic agents, alkylating - adverse effects (1) 1
antineoplastic agents, alkylating - therapeutic use (1) 1
anxiety (1) 1
article (1) 1
autonomy (1) 1
bevacizumab - administration & dosage (1) 1
bevacizumab - adverse effects (1) 1
bioindicators (1) 1
biomarkers (1) 1
bolus 5-fluorouracil (1) 1
brain cancer-patients (1) 1
brain neoplasms - psychology (1) 1
brain research (1) 1
brain-tumor group (1) 1
care and treatment (1) 1
chemoradiotherapy (1) 1
clinic for neurology (1) 1
clinical investigations (1) 1
clinical neurology (1) 1
cognition (1) 1
colorectal neoplasms - drug therapy (1) 1
colorectal neoplasms - mortality (1) 1
combination chemotherapy (1) 1
combined modality therapy - methods (1) 1
computed-tomography (1) 1
confidence intervals (1) 1
controlled-trial (1) 1
cooperative oncology group (1) 1
cross-sectional studies (1) 1
delivery systems (1) 1
deoxyribonucleic acid--dna (1) 1
dna methylation (1) 1
dna methyltransferase (1) 1
dosage and administration (1) 1
dose folinic acid (1) 1
dose-response (1) 1
drug development (1) 1
drug therapy (1) 1
editor's choice (1) 1
european organization (1) 1
european-organization (1) 1
evidence-driven optimal health-care delivery (1) 1
family physicians (1) 1
fluorouracil plus leucovorin (1) 1
glioblastoma - mortality (1) 1
glioblastoma - radiotherapy (1) 1
glioblastoma multiforme (1) 1
glioma (1) 1
glioma - drug therapy (1) 1
glioma - mortality (1) 1
glioma - psychology (1) 1
glioma - radiotherapy (1) 1
gliomas (1) 1
grade gliomas (1) 1
greece (1) 1
health care surveys (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 11, pp. 1533 - 1542
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2017, Volume 377, Issue 20, pp. 1954 - 1963
The addition of bevacizumab to lomustine in patients with recurrent glioblastoma failed to increase overall survival but was associated with a small increase... 
MEDICINE, GENERAL & INTERNAL | METHYLATION | PROGNOSTIC-FACTORS | PLUS IRINOTECAN | SINGLE-AGENT BEVACIZUMAB | RESPONSE ASSESSMENT | CLINICAL-TRIALS | PHASE-2 | QUALITY-OF-LIFE | RADIOTHERAPY | TEMOZOLOMIDE | Bevacizumab - administration & dosage | Bevacizumab - adverse effects | Humans | Lomustine - adverse effects | Middle Aged | Kaplan-Meier Estimate | Male | Antineoplastic Agents, Alkylating - administration & dosage | Brain Neoplasms - drug therapy | Chemoradiotherapy | Glioblastoma - radiotherapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Aged, 80 and over | Adult | Female | Aged | Brain Neoplasms - mortality | Antineoplastic Agents, Alkylating - adverse effects | Brain Neoplasms - radiotherapy | Glioblastoma - drug therapy | Glioblastoma - mortality | Lomustine - administration & dosage | Patient outcomes | Lomustine | Outcome and process assessment (Health Care) | Dosage and administration | Research | Drug therapy | Glioblastoma multiforme | Methods | Medical research | Nuclear magnetic resonance--NMR | Brain cancer | Methylguanine | Glioblastoma | Clinical trials | Oncology | Cognition | Cancer therapies | Survival | Quality of life | Bevacizumab | O6-methylguanine-DNA methyltransferase | Studies | Brain research | DNA methylation | DNA methyltransferase | Methylation | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 06/2019, Volume 114, pp. 128 - 136
Academic, industry, regulatory leaders and patient advocates in cancer clinical research met in November 2018 at the Innovation and Biomarkers in Cancer Drug... 
Biomarkers | Clinical trials | Evidence-driven optimal health-care delivery | Health technology assessment | Molecular and immunologic profiling | Medical research | Profiling | Therapeutic applications | Delivery systems | Drug development | Bioindicators | New technology | Autonomy | Deoxyribonucleic acid--DNA | Tumors | Cancer
Journal Article
Clinical and Translational Oncology, ISSN 1699-048X, 6/2006, Volume 8, Issue 6, pp. 444 - 449
Despite unique tumor epidemiology and a higher cancer incidence compared to pediatric patients, adolescents and young adults have not been receiving... 
Medicine & Public Health | adolescents | young adults | Oncology | cancer | chemotherapy | juvenile oncology | Juvenile oncology | Chemotherapy | Young adults | Adolescents | Cancer
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.